Results
|
|
81881.
|
|
|
|
81882.
|
|
|
|
81883.
|
Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial. [electronic resource] by
- Burmeister, Bryan H
- Henderson, Michael A
- Ainslie, Jill
- Fisher, Richard
- Di Iulio, Juliana
- Smithers, B Mark
- Hong, Angela
- Shannon, Kerwin
- Scolyer, Richard A
- Carruthers, Scott
- Coventry, Brendon J
- Babington, Scott
- Duprat, Joao
- Hoekstra, Harald J
- Thompson, John F
Producer: 20120815
In:
The Lancet. Oncology vol. 13
Availability: No items available.
|
|
|
81884.
|
|
|
|
81885.
|
|
|
|
81886.
|
|
|
|
81887.
|
Toxicarioside A inhibits tumor growth and angiogenesis: involvement of TGF-β/endoglin signaling. [electronic resource] by
- Huang, Feng-Ying
- Mei, Wen-Li
- Li, Yue-Nan
- Tan, Guang-Hong
- Dai, Hao-Fu
- Guo, Jun-Li
- Wang, Hua
- Huang, Yong-Hao
- Zhao, Huan-Ge
- Zhou, Song-Lin
- Lin, Ying-Ying
Producer: 20130624
In:
PloS one vol. 7
Availability: No items available.
|
|
|
81888.
|
|
|
|
81889.
|
|
|
|
81890.
|
|
|
|
81891.
|
|
|
|
81892.
|
PI3K/AKT signaling is essential for communication between tissue-infiltrating mast cells, macrophages, and epithelial cells in colitis-induced cancer. [electronic resource] by
- Khan, Mohammad W
- Keshavarzian, Ali
- Gounaris, Elias
- Melson, Joshua E
- Cheon, Eric C
- Blatner, Nichole R
- Chen, Zongmin E
- Tsai, Fu-Nien
- Lee, Goo
- Ryu, Hyunji
- Barrett, Terrence A
- Bentrem, David J
- Beckhove, Philipp
- Khazaie, Khashayarsha
Producer: 20131112
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 19
Availability: No items available.
|
|
|
81893.
|
|
|
|
81894.
|
|
|
|
81895.
|
|
|
|
81896.
|
Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancer. [electronic resource] by
- Tekedereli, Ibrahim
- Alpay, S Neslihan
- Tavares, Clint D J
- Cobanoglu, Zehra E
- Kaoud, Tamer S
- Sahin, Ibrahim
- Sood, Anil K
- Lopez-Berestein, Gabriel
- Dalby, Kevin N
- Ozpolat, Bulent
Producer: 20130419
In:
PloS one vol. 7
Availability: No items available.
|
|
|
81897.
|
|
|
|
81898.
|
Cediranib with mFOLFOX6 versus bevacizumab with mFOLFOX6 as first-line treatment for patients with advanced colorectal cancer: a double-blind, randomized phase III study (HORIZON III). [electronic resource] by
- Schmoll, Hans-Joachim
- Cunningham, David
- Sobrero, Alberto
- Karapetis, Christos S
- Rougier, Philippe
- Koski, Sheryl L
- Kocakova, Ilona
- Bondarenko, Igor
- Bodoky, György
- Mainwaring, Paul
- Salazar, Ramon
- Barker, Peter
- Mookerjee, Bijoyesh
- Robertson, Jane
- Van Cutsem, Eric
Producer: 20121219
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 30
Availability: No items available.
|
|
|
81899.
|
Cediranib plus FOLFOX/CAPOX versus placebo plus FOLFOX/CAPOX in patients with previously untreated metastatic colorectal cancer: a randomized, double-blind, phase III study (HORIZON II). [electronic resource] by
- Hoff, Paulo M
- Hochhaus, Andreas
- Pestalozzi, Bernhard C
- Tebbutt, Niall C
- Li, Jin
- Kim, Tae Won
- Koynov, Krassimir D
- Kurteva, Galina
- Pintér, Tamás
- Cheng, Ying
- van Eyll, Brigitte
- Pike, Laura
- Fielding, Anitra
- Robertson, Jane D
- Saunders, Mark P
Producer: 20121219
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 30
Availability: No items available.
|
|
|
81900.
|
|